| Controls n = 597 | UCTD n = 131 | Major rheumatic diseases n = 68 | No criteria for diagnosis n = 150 |
---|---|---|---|---|
N. of items | N (%) | N (%) | N (%) | N (%) |
 1 | - | 8 (61.1) | 8 (11.8) | - |
 2 | - | 54 (41.2) | 24 (35.3) | 87 (58) |
 >2 | - | 69 (52.7) | 36 (52.9) | 63 (42) |
ANA titre | ||||
 1:80 | 24 (4) | 42 (32.1) | 13 (19.1) | 82 (54.6) |
 1:160 | 8 (1.3) | 46 (35.1) | 16 (23.5) | 26 (17.3) |
  > 1:160 |  | 43 (32.8) | 26 (38.2) | 11 (7.3) |
dsDNA | 0 | 5 (3.8) | 8 (11.7) | 2 (1.3) |
ENA | 0 | 17 (12.9) | 22 (32.4) | 0 |
aCLIgG | 0 | 6 (4.6) | 10 (14.7) | 9 (6) |
aCL IgM | 1 (0.16) | 14 (10.7) | 11 (16.2) | 22 (14.6) |
beta2GP1IgG | 0 | 4 (3.05) | 8 (11.7) | 8 (5.3) |
LAC | 0 | 1 (0.76) | 9 (13.2) | 0 |